259 related articles for article (PubMed ID: 6579963)
1. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
Maxwell RE; Nawrocki JW; Uhlendorf PD
Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
[TBL] [Abstract][Full Text] [Related]
2. Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed rats.
Krause BR; Newton RS
Atherosclerosis; 1986 Jan; 59(1):95-8. PubMed ID: 3081014
[TBL] [Abstract][Full Text] [Related]
3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
4. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
Hall MJ; Nelson LM; Russell RI; Howard AN
Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
[TBL] [Abstract][Full Text] [Related]
5. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
Fears R; Richards DH; Ferres H
Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
Krause BR; Newton RS
J Lipid Res; 1985 Aug; 26(8):940-9. PubMed ID: 3862732
[TBL] [Abstract][Full Text] [Related]
7. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
Krause BR; Barnett BC; Essenburg AD; Kieft KA; Auerbach BJ; Bousley R; Stanfield R; Newton RS; Bisgaier CL
Atherosclerosis; 1996 Nov; 127(1):91-101. PubMed ID: 9006809
[TBL] [Abstract][Full Text] [Related]
8. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
Kähönen MT; Ylikahri RH
Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
[TBL] [Abstract][Full Text] [Related]
9. The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.
Shand JH; West DW
Lipids; 1994 Nov; 29(11):747-52. PubMed ID: 7869854
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Kłosiewicz-Latoszek L; Szostak WB
Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of adipocyte cholesterol during hypolipidemic drug treatment in cholesterol-fed rats.
Krause BR; Hartman AD
Biochim Biophys Acta; 1982 Dec; 713(3):485-93. PubMed ID: 7150624
[TBL] [Abstract][Full Text] [Related]
12. Some effects of chitosan on liver function in the rat.
LeHoux JG; Grondin F
Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
[TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T
J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480
[TBL] [Abstract][Full Text] [Related]
14. Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.
Ståhlberg D; Angelin B; Einarsson K
J Lipid Res; 1989 Jul; 30(7):953-8. PubMed ID: 2794793
[TBL] [Abstract][Full Text] [Related]
15. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
Turley SD; Dietschy JM
J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
[TBL] [Abstract][Full Text] [Related]
16. Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects.
Leiss O; von Bergmann K; Gnasso A; Augustin J
Metabolism; 1985 Jan; 34(1):74-82. PubMed ID: 3855325
[TBL] [Abstract][Full Text] [Related]
17. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
[TBL] [Abstract][Full Text] [Related]
19. Effects of peroxisome proliferators gemfibrozil and clofibrate on syntheses of dolichol and cholesterol in rat liver.
Shiota Y; Ikeda M; Hashimoto F; Hayashi H
J Biochem; 2003 Aug; 134(2):197-202. PubMed ID: 12966067
[TBL] [Abstract][Full Text] [Related]
20. Influence of gemfibrozil on high-density lipoproteins.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
